Abstract

Eyes are delicate and most vital organs of the body whose defence mechanism restricts entry of exogenous substance. Conventional drug delivery systems get washed off within a short period of time that usually cause poor bioavailability and therapeutic responses because high tear fluid turnover and dynamics cause rapid elimination of the drug from the eye. In-situ gelling ophthalmic drug delivery system is one of the new methods that is developed to overcome this bioavailability problems. In-situ gelling systems are viscous polymerbased liquids that exhibit sol-to-gel phase transition on the ocular surface due to a change in a specific physicochemical parameter like temperature, ionic strength, or pH triggered in-situ systems. Using this formulation of pH triggered in-situ gel systems, the release of drug can be sustained for longer periods of time, therapeutically more efficacious, non-irritant and stable than conventional eye drops.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call